We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Globalization Act Introduced, Includes New Fees, Inspections and Subpoenas
FDA Globalization Act Introduced, Includes New Fees, Inspections and Subpoenas
January 30, 2009
The FDA Globalization Act has been introduced in the House, and it includes user fee provisions for generic drug applications starting in October.